Gene: PARP4
Official Full Name: poly(ADP-ribose) polymerase family member 4provided by HGNC
Gene Summary: This gene encodes poly(ADP-ribosyl)transferase-like 1 protein, which is capable of catalyzing a poly(ADP-ribosyl)ation reaction. This protein has a catalytic domain which is homologous to that of poly (ADP-ribosyl) transferase, but lacks an N-terminal DNA binding domain which activates the C-terminal catalytic domain of poly (ADP-ribosyl) transferase. Since this protein is not capable of binding DNA directly, its transferase activity may be activated by other factors such as protein-protein interaction mediated by the extensive carboxyl terminus. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO39098 | PARP4 Knockout cell line (HeLa) | Human | PARP4 | 1:3~1:6 | Negative | Online Inquiry |
KO39099 | PARP4 Knockout cell line (HCT 116) | Human | PARP4 | 1:2~1:4 | Negative | Online Inquiry |
KO39100 | PARP4 Knockout cell line (HEK293) | Human | PARP4 | 1:3~1:6 | Negative | Online Inquiry |
KO39101 | PARP4 Knockout cell line (A549) | Human | PARP4 | 1:3~1:4 | Negative | Online Inquiry |
PARP4 Gene Knockout Cell Lines are a revolutionary tool in cellular and molecular biology, engineered to specifically disrupt the PARP4 gene. This product enables researchers to study the functional consequences of PARP4 loss, which is critical for investigating its role in various biological processes, including DNA repair, cell signaling, and cancer progression. By utilizing CRISPR/Cas9 technology, these knockout cell lines provide a precise and efficient method for gene editing, resulting in reproducible and robust phenotypic outcomes.
The primary function of PARP4, also known as PARP-4 or tankyrase 1, revolves around its involvement in the poly(ADP-ribosyl)ation process, which modifies proteins and regulates diverse cellular responses. Understanding how the deletion of PARP4 influences cellular pathways can reveal insights into its role in tumor biology, particularly in cancers that exhibit altered DNA repair mechanisms. Researchers can employ these knockout cells to elucidate the molecular interactions and pathways affected by PARP4, paving the way for potential therapeutic targets in oncology.
In comparison to existing alternatives for gene manipulation, PARP4 Gene Knockout Cell Lines offer superior specificity and efficiency. Conventional methods, such as RNA interference, can lead to off-target effects and variable knockdown efficiencies. In contrast, the CRISPR-based design ensures precise gene disruption, allowing for more straightforward data interpretation and reliable reproducibility in experimental outcomes.
For scientists and clinicians dedicated to advancing knowledge in cancer research, genetic disorders, and cellular responses to damage, PARP4 Gene Knockout Cell Lines serve as an invaluable resource. Their versatility and potential for high-impact discoveries make them an essential addition to any laboratory focused on genetic and epigenetic studies.
At [Your Company Name], we specialize in the development of innovative biological products designed to empower researchers in their quest for scientific advancement. Our expertise in gene editing technologies ensures that our offerings, including PARP4 Gene Knockout Cell Lines, are of the highest quality and tailored to meet the rigorous demands of contemporary research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.